Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL

Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM study

Published:2022-10-19 Issue: Volume: Page:
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Varettoni Marzia¹^ORCID,Zibellini Silvia¹,Merli Michele²^ORCID,Drandi Daniela³,Jiménez Cristina⁴,Furlan Daniela⁵,Ferretti Virginia Valeria⁶,Fabbri Nicole⁷,Dogliotti Irene⁸,Varraso Chiara¹,Ferrante Martina³,Cappello Emilia⁷,Peri Veronica⁸,Cavalloni Chiara¹,Borriero Michela³,Facchetti Giulia Vittoria⁷,Ferrero Simone³⁸,Arcaini Luca¹⁷^ORCID,Garcia‐Sanz Ramon⁴

Affiliation:

1. Division of Hematology Fondazione IRCCS Policlinico San Matteo Pavia Italy

2. Department of Hematology University Hospital “Ospedale di Circolo e Fondazione Macchi – ASST Sette Laghi” Varese Italy

3. Department of Molecular Biotechnology and Health Sciences University of Torino Torino Italy

4. Department of Hematology University Hospital of Salamanca (HUS/IBSAL) CIBERONC and Cancer Research Institute of Salamanca‐IBMCC (USAL‐CSIC) Salamanca Spain

5. Unit of Anatomic Pathology University of Insubria Varese Italy

6. UOS Clinical Epidemiology and Biostatistic Fondazione IRCCS Policlinico San Matteo Pavia Italy

7. Department of Molecular Medicine University of Pavia Pavia Italy

8. Hematology A.O.U. Città della Salute e della Scienza University of Torino Torino Italy

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.3082

Reference15 articles.

1. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia

2. Genomic Landscape of Waldenström Macroglobulinemia and Its Impact on Treatment Strategies

3. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia;Leukemia;2024-02-26